Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianlong Jia

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
British Journal of Pharmacology|July 1, 2026
Targeting KRAS for cancer therapyJianlong Jia, Ruonan Liu, Tonia A Adamide, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2021
Outcomes of local thoracic surgery in patients with stage IV non-small-cell lung cancer: A SEER-based analysisJianlong Jia, Bin Guo, Zhiyi Yang, et al.
Frontiers in Immunology|August 4, 2022
Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular CarcinomaJianlong Jia, Latai Ga, Yang Liu, et al.
Translational Oncology|August 25, 2024
Improved survival of patients with stage III small-cell lung cancer with primary resection: A SEER-based analysisJianlong Jia, Lilith Trassl, Fanli Kong, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|August 27, 2021
Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cellsAbdullah Shopit, Xiaodong Li, Shisheng Wang, et al.
Translational Oncology|October 15, 2023
Clinical identification of malignant pleural effusionsJianlong Jia, Antonia Marazioti, Apostolos Voulgaridis, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
British Journal of Pharmacology|July 1, 2026
Targeting KRAS for cancer therapyJianlong Jia, Ruonan Liu, Tonia A Adamide, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2021
Outcomes of local thoracic surgery in patients with stage IV non-small-cell lung cancer: A SEER-based analysisJianlong Jia, Bin Guo, Zhiyi Yang, et al.
Frontiers in Immunology|August 4, 2022
Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular CarcinomaJianlong Jia, Latai Ga, Yang Liu, et al.
Translational Oncology|August 25, 2024
Improved survival of patients with stage III small-cell lung cancer with primary resection: A SEER-based analysisJianlong Jia, Lilith Trassl, Fanli Kong, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|August 27, 2021
Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cellsAbdullah Shopit, Xiaodong Li, Shisheng Wang, et al.
Translational Oncology|October 15, 2023
Clinical identification of malignant pleural effusionsJianlong Jia, Antonia Marazioti, Apostolos Voulgaridis, et al.
Pageof 1